Keyphrases
Rhabdomyosarcoma Cells
100%
Histone Methyltransferase
100%
Nuclear Receptor 4A1
100%
Alveolar Rhabdomyosarcoma
100%
Methylase Genes
100%
H3K9me3
25%
Knockdown
16%
Regulated Genes
16%
Receptor Antagonist
16%
Gene Expression
8%
Nur77
8%
Decreased Expression
8%
Rhabdomyosarcoma
8%
Cancer Cell Lines
8%
Methylation
8%
Oncogenic Activity
8%
Tumor Growth
8%
Tumor Subtype
8%
Bromo
8%
Breast Cancer Cells
8%
Athymic nude Mice
8%
Dimethyl 3
8%
Orphan nuclear Receptor
8%
Lysine
8%
Gene Silencing
8%
Methoxy
8%
Tumor Promoter
8%
Mechanistic Studies
8%
Lung Cancer Cells
8%
GC-rich
8%
Methane
8%
Histone H3
8%
P-hydroxyphenyl
8%
Endometrial Cancer Cells
8%
Pro-oncogenic
8%
Indolyl
8%
EHMT2
8%
Liver Cancer Stem Cells
8%
Bisindole
8%
Anta
8%
Medicine and Dentistry
Cell Nucleus Receptor
100%
Rhabdomyosarcoma
100%
Histone Methyltransferase
100%
Promoter Region
18%
Receptor Antagonist
18%
Messenger RNA
9%
Neoplasm
9%
Lung
9%
Tumor Progression
9%
Gene Expression
9%
Cancer Cell
9%
Uterine Cancer
9%
Methylation
9%
Gene Inactivation
9%
Tumor Promoter
9%
Orphan Nuclear Receptor
9%
Cancer Cell Line
9%
Histone H3
9%
Lysine
9%
Oncogenic activity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Rhabdomyosarcoma
100%
Cell Nucleus Receptor
100%
Histone Methyltransferase
100%
Receptor Antagonist
18%
Malignant Neoplasm
9%
Neoplasm
9%
Messenger RNA
9%
Nude Mouse
9%
Tumor Growth
9%
Endometrium Cancer
9%
Tumor Promoter
9%
Indole
9%
Histone H3
9%
Lysine
9%
Orphan Nuclear Receptor
9%
Oncogenic activity
9%
Biochemistry, Genetics and Molecular Biology
Nuclear Receptor
100%
Histone Methyltransferase
100%
Promoter Region
27%
Cancer Cell
18%
Receptor Antagonist
18%
Gene Expression
9%
Messenger RNA
9%
Methylation
9%
Nude Mouse
9%
Lysine
9%
Gene Inactivation
9%
Tumor Progression
9%
Orphan Nuclear Receptor
9%
In Vivo Study
9%
Histone H3
9%
EHMT2
9%
Oncogenic activity
9%